Literature DB >> 23828733

Risk factors for "PTH spikes" during surgery for primary hyperparathyroidism.

Philipp Riss1, Christoph Krall, Christian Scheuba, Christian Bieglmayer, Bruno Niederle.   

Abstract

PURPOSE: Increased intraoperative parathyroid hormone excretion ("PTH spikes") due to unintended manipulation of parathyroid adenoma can be observed frequently during surgery for primary hyperparathyroidism. This may lead to difficulties in interpreting intraoperative PTH curves. The aim of this study was to elucidate possible risk factors for PTH spikes and to evaluate the impact on different interpretation criteria of intraoperative PTH curves.
METHODS: Eight hundred forty-seven patients with primary hyperparathyroidism were included. The probability of PTH spikes was analyzed regarding preoperative PTH- and creatinine levels, and size of adenoma and their impact on the Vienna, Miami, and Halle criteria was evaluated.
RESULTS: PTH spikes occurred in 102 patients (12 %) and revealed to be independent of PTH- and creatinine levels (p = 0.13) preoperatively. There was a significant negative correlation between "manipulation PTH" and "baseline PTH" values and the gland volume, respectively. Patients presenting with smaller adenomas and those with low-baseline PTH values show significantly higher manipulation values. No risk factor for manipulation was exposed and no significantly higher risk of misclassification as "false positive" in case of PTH spikes was detected for any interpretation criterion. For the "Vienna Criterion," however, a significant increase in the risk of "false negative" misclassification was observed with increasing manipulation values.
CONCLUSIONS: In patients with PTH spikes, none of the analyzed criteria show a significant increase in missed adenomas. Nevertheless, the Vienna criterion shows a higher rate of potentially unnecessary explorations with increasing manipulation values. Thus, caution is warranted in detecting PTH spikes and in individual interpretations of specific PTH curves is recommended. The Miami criterion seems to be favorable in this group of patients.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23828733     DOI: 10.1007/s00423-013-1097-y

Source DB:  PubMed          Journal:  Langenbecks Arch Surg        ISSN: 1435-2443            Impact factor:   3.445


  33 in total

Review 1.  [The value of preoperative localization studies in primary hyperparathyroidism].

Authors:  G Prager; C Czerny; A Kurtaran; C Passler; C Scheuba; B Niederle
Journal:  Chirurg       Date:  1999-10       Impact factor: 0.955

2.  Impact of localization studies on feasibility of minimally invasive parathyroidectomy in an endemic goiter region.

Authors:  Gerhard Prager; Christian Czerny; Sedan Ofluoglu; Amir Kurtaran; Christian Passler; Klaus Kaczirek; Christian Scheuba; Bruno Niederle
Journal:  J Am Coll Surg       Date:  2003-04       Impact factor: 6.113

3.  Comment on "A rising ioPTH level immediately after parathyroid resection: are additional hyperfunctioning glands always present? An application of the Wisconsin Criteria".

Authors:  Philipp Riss; Christian Bieglmayer; Bruno Niederle
Journal:  Ann Surg       Date:  2011-10       Impact factor: 12.969

4.  A selective, Bayesian approach to intraoperative PTH monitoring.

Authors:  Roy S Hwang; Lilah F Morris; Kevin Ro; Steven Park; Philip H G Ituarte; Joe C Hong; Michael W Yeh
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

5.  A rising ioPTH level immediately after parathyroid resection: are additional hyperfunctioning glands always present? An application of the Wisconsin Criteria.

Authors:  Mackenzie R Cook; Susan C Pitt; Sarah Schaefer; Rebecca Sippel; Herbert Chen
Journal:  Ann Surg       Date:  2010-06       Impact factor: 12.969

6.  Does the final intraoperative PTH level really have to fall into the normal range to signify cure?

Authors:  Alexandra E Reiher; Sarah Schaefer; Herbert Chen; Rebecca S Sippel
Journal:  Ann Surg Oncol       Date:  2011-12-28       Impact factor: 5.344

7.  A comparison of outcomes for younger and older adult patients undergoing surgery for primary hyperparathyroidism.

Authors:  Emad Kandil; Dewan Safwan Majid; Kathryn A Carson; Ralph P Tufano
Journal:  Ann Surg Oncol       Date:  2011-12-30       Impact factor: 5.344

Review 8.  Intraoperative adjuncts in surgery for primary hyperparathyroidism.

Authors:  Barney J Harrison; Frederic Triponez
Journal:  Langenbecks Arch Surg       Date:  2009-07-10       Impact factor: 3.445

9.  Is minimally invasive parathyroidectomy without QPTH monitoring justified?

Authors:  Philipp Riss; Christian Scheuba; Reza Asari; Christian Bieglmayer; Bruno Niederle
Journal:  Langenbecks Arch Surg       Date:  2009-05-14       Impact factor: 3.445

10.  Parathyroid surgical failures with misleading falls of intraoperative parathyroid hormone levels.

Authors:  J Horányi; L Duffek; R Szlávik; K Darvas; P Lakatos; M Tóth; K Rácz
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

View more
  3 in total

1.  Management of primary and renal hyperparathyroidism: guidelines from the German Association of Endocrine Surgeons (CAEK).

Authors:  T Weber; C Dotzenrath; H Dralle; B Niederle; P Riss; K Holzer; J Kußmann; A Trupka; T Negele; R Kaderli; E Karakas; F Weber; N Rayes; A Zielke; M Hermann; C Wicke; R Ladurner; C Vorländer; J Waldmann; O Heizmann; S Wächter; S Schopf; W Timmermann; D K Bartsch; R Schmidmaier; M Luster; K W Schmid; M Ketteler; C Dierks; P Schabram; T Steinmüller; K Lorenz
Journal:  Langenbecks Arch Surg       Date:  2021-04-21       Impact factor: 3.445

2.  PTH Spikes During Surgical Treatment for Secondary and Tertiary Hyperparathyroidism: A Prospective Observational Study.

Authors:  Andre Albuquerque Silveira; Marilia D'Elboux Guimaraes Brescia; Climerio Pereira do Nascimento; Felipe Ferraz Magnabosco; Sergio Samir Arap; Fabio Luiz de Menezes Montenegro
Journal:  World J Surg       Date:  2022-03-09       Impact factor: 3.282

3.  Applicability of a shortened interpretation model for intraoperative parathyroid hormone monitoring in patients with primary hyperparathyroidism in an endemic goiter region.

Authors:  Philipp Riss; Angelika Geroldinger; Andreas Selberherr; Lindsay Brammen; Julian Heidtmann; Christian Scheuba
Journal:  Eur Surg       Date:  2018-07-11       Impact factor: 0.953

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.